Adrian Rabin
Lawyers
Associate in our IP, Tech & Commercial Transactions practice.
Experience highlights
Recent Representations
- Korro Bio $70 million private placement
- Intra-Cellular Therapies $500 million stock offering
- Nurix Therapeutics $175 million stock and pre-funded warrants offering
- Stoke Therapeutics $125 million stock and pre-funded warrants offering
- Metagenomi $93.75 million IPO
- MSCI acquisition of Foxberry
- Immatics $201 million follow-on offering
- Roche $295 million acquisition of LumiraDx's point of care technology platform
- MSCI acquisition of Fabric RQ
- Smith+Nephew acquisition of CartiHeal
- Sealed Air $425 million senior notes offering and concurrent tender offer
- Newfold Digital Holdings Group $515 million senior secured notes offering
- Immedica Pharma acquisition of pegzilarginase assets from Aeglea
- Korro Bio $117 million private placement
- Oculis Holding $40.25 million debut equity offering
- Seagate HDD Cayman $1 billion senior notes offering
Education
J.D., Cornell Law School
- Online Editor, Cornell International Law Journal
B.A., Biology, Emory University
Professional history
- Davis Polk since 2022
Qualifications and admissions
- State of New York
- U.S. District Court, S.D. New York